553705 - Summitt Retirement Announce

Alzheimer’s diagnoses rising in Oregon, with 79,000 affected and counting

553709 - Pat Summitt Tyler 1990

Retired neurologist who studied Alzheimer's is in the early stages himself

553704 - Pat Summitt 1998

Researchers share progress of new Alzheimer's treatments

553708 - tyler Summitt 1990

2023 brought new research, breakthrough treatments for Alzheimer's disease

553701 - Pat Summitt 1987

Supporting Oregon rural healthcare workers with Alzheimer's detection resources

553703 - Pat Summitt 1991

Twin Cities media personalities join in the fight against Alzheimer's

New developments in medicine offer hope on Alzheimer’s disease

Four tips to reduce your chances of Alzheimer's

Man pedals across the country for Alzheimer's

OHSU researchers discover new possible cause of Alzheimer’s and vascular dementia

Oregon man to ride cross-country to raise awareness for Alzheimer’s

Coping with Alzheimer's disease: HealthLink

Living with Dementia | What it’s like inside a caregiver’s home

Compound in flowers could help fight cancer

Pounding the pavement for Alzheimer’s disease in St. Petersburg

Country-rock singer Jay Allen has helped raise $160M to fight Alzheimer's disease

Walk To End Alzheimer's unites families

Alzheimer's and its impact on the Latino community

Alzheimer’s patient and family make memories at Portland International Raceway

More than 350k Alzheimer's caregivers in Tennessee are unpaid as impact of disease projected to rise

Families on Alzheimer's, dementia journey have safe care option with Ebenezer DayBreak

Thousands attend Walk to End Alzheimer's, Twin Cities on Saturday

Alzheimer’s drug Leqembi receives full FDA approval

Free tests for Alzheimer's in November in New Orleans

Oratorio Society of Minnesota performs 'Alzheimer's Stories'

FDA approves breakthrough Alzheimer's drug

Groundbreaking Alzheimer's treatment offers hope

FDA approval of latest Alzheimer's drug gives MN families hope

FDA panel approves Alzheimer's drug that can slow disease

New Alzheimer’s report highlights caregiver and workforce challenges

FDA committee advances Alzheimer's drug

Alzheimer’s Association hosting Brews & Beats fundraiser to raise awareness of disease

Alzheimer’s Therapeutic Research Institute celebrates 10 years of progress in Alzheimer's prevention

FDA approves Eli Lilly's Alzheimer's medication

Walk to End Alzheimer's raises awareness and funds for Alzheimer care, support and research

Forgetting To Remember | An Alzheimer’s story